These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32776284)

  • 21. The effects of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat.
    Salter M; Hazelwood R; Pogson CI; Iyer R; Madge DJ
    Biochem Pharmacol; 1995 May; 49(10):1435-42. PubMed ID: 7539265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
    Kim M; Tomek P
    Front Immunol; 2021; 12():636081. PubMed ID: 33708223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan 2,3-dioxygenase in tumor cells is associated with resistance to immunotherapy in renal cell carcinoma.
    Sumitomo M; Takahara K; Zennami K; Nagakawa T; Maeda Y; Shiogama K; Yamamoto Y; Muto Y; Nukaya T; Takenaka M; Fukaya K; Ichino M; Sasaki H; Saito K; Shiroki R
    Cancer Sci; 2021 Mar; 112(3):1038-1047. PubMed ID: 33410234
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
    J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
    Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z
    Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase.
    Capece L; Arrar M; Roitberg AE; Yeh SR; Marti MA; Estrin DA
    Proteins; 2010 Nov; 78(14):2961-72. PubMed ID: 20715188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase.
    Schmidt SK; Müller A; Heseler K; Woite C; Spekker K; MacKenzie CR; Däubener W
    Eur J Immunol; 2009 Oct; 39(10):2755-64. PubMed ID: 19637229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through control of cell heme allocation by nitric oxide.
    Biswas P; Stuehr DJ
    J Biol Chem; 2023 Jun; 299(6):104753. PubMed ID: 37116709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Reaction Intermediates in Tryptophan 2,3-Dioxygenase: A Comparison with Indoleamine 2,3-Dioxygenase.
    Basran J; Booth ES; Lee M; Handa S; Raven EL
    Biochemistry; 2016 Dec; 55(49):6743-6750. PubMed ID: 27951658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors.
    Schramme F; Crosignani S; Frederix K; Hoffmann D; Pilotte L; Stroobant V; Preillon J; Driessens G; Van den Eynde BJ
    Cancer Immunol Res; 2020 Jan; 8(1):32-45. PubMed ID: 31806638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
    Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
    J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
    Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
    Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO).
    Pan S; Zhou Y; Wang Q; Wang Y; Tian C; Wang T; Huang L; Nan J; Li L; Yang S
    Eur J Med Chem; 2020 Dec; 207():112703. PubMed ID: 32871341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contributions of tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase to the conversion of D-tryptophan to nicotinamide analyzed by using tryptophan 2,3-dioxygenase-knockout mice.
    Maeta A; Sano M; Fukuwatari T; Funakoshi H; Nakamura T; Shibata K
    Biosci Biotechnol Biochem; 2014; 78(5):878-81. PubMed ID: 25035993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepG2 Tumor Cells.
    Oweira H; Lahdou I; Mehrle S; Khajeh E; Nikbakhsh R; Ghamarnejad O; Terness P; Reißfelder C; Sadeghi M; Ramouz A
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of paeoniflorin from Paeonia lactiflora pall. As an inhibitor of tryptophan 2,3-dioxygenase and assessment of its pharmacological effects on depressive mice.
    Liang X; Su T; Wu P; Dai Y; Chen Y; Wang Q; Cao C; Chen F; Wang Q; Wang S
    J Ethnopharmacol; 2023 Dec; 317():116714. PubMed ID: 37315645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
    Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
    Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative and spatial differences in the expression of tryptophan-metabolizing enzymes in mouse epididymis.
    Britan A; Maffre V; Tone S; Drevet JR
    Cell Tissue Res; 2006 May; 324(2):301-10. PubMed ID: 16450123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tryptophan degradation enzymes expression in the placenta and the Kynurenine/Tryptophan ratio in maternal plasma after elective cesarean section.
    Silvano A; Seravalli V; Strambi N; Vallario A; Tofani L; Parenti A; Di Tommaso M
    J Reprod Immunol; 2023 Mar; 156():103823. PubMed ID: 36739732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth.
    Pfeifer S; Schreder M; Bolomsky A; Graffi S; Fuchs D; Sahota SS; Ludwig H; Zojer N
    J Cancer Res Clin Oncol; 2012 Nov; 138(11):1821-30. PubMed ID: 22722711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.